Medical aesthetic devices are used to treat impairments associated with a persons aesthetic appearance or enhance the same. In addition, these devices (particularly implants) rectify the malformations caused due to accidents, trauma, and other congenital disorders.

The global medical aesthetic devices market was valued at $9,235 million in 2016, and is expected to reach at $17,992 million by 2023, growing at a CAGR of 10.0% from 2017 to 2023. The dental implants segment accounted for more than one-third share of the total market in 2016.

Download Sample @ https://www.alliedmarketresearch.com/request-sample/892

The medical aesthetics devices market is driven by increase in technological advancements, high demand for minimally invasive and non-invasive reconstruction surgeries, rise in incidence of congenital face and tooth deformities, and growth in awareness for aesthetic appearance. However, this growth is limited due to high cost of treatment, low reimbursements, and risk of malfunctions associated with implants. Growth of medical tourism industry, emergence of tourism medical spas, and adoption of aesthetic procedures to enhance physical appearance are expected to provide several opportunities for key market players.

The dental implants segment is expected to maintain its dominant position throughout the analysis period, due to increase in demand for cosmetic dentistry and high incidence rate of tooth loss. In addition, the aesthetic laser segment is expected to grow at the highest CAGR of 14.9% from 2017 to 2023.

The major companies profiled in the report include Allergan PLC, Solta Medical Inc. (a division of Valeant Pharmaceuticals International Inc.), Syneron Medical Ltd., Cynosure Inc. (a division of Hologic, Inc.), Lumenis Ltd., Johnson & Johnson, Merz Pharma GmbH & Co. KGaA, Alma Lasers Ltd. (acquired By Shanghai Fosun Pharmaceutical (Group) Co. Ltd.),

Key Findings of the Medical Aesthetic Devices Market:

The aesthetic implants segment accounted for three-fourths share of the total market in 2016.
The non-surgical segment accounted for a high CAGR of 10.9% from 2017 to 2023.
Hospitals & clinics accounted for more than three-fifths of the total market in 2016.
Asia-Pacific is expected grow at the highest CAGR of 11.5% from 2017 to 2022.

Send Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/892

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.